The science behind health insights

Family medical history is a well-established risk factor for many common diseases. Studies have found that having a positive family history of a given chronic condition is associated with roughly a 2- to 5-fold increase in the relative risk of developing that condition.¹

In other words, people with affected first-degree relatives are several times more likely to develop the same disease than those with no such family history. This effect spans multiple common diseases — for example, an analysis of older adults in India showed that individuals with a family history of hypertension, diabetes, heart disease, stroke, or cancer had about 1.6 to 2.9 times higher odds of having those conditions themselves compared to those without family history.²

The magnitude of risk can be even greater if multiple relatives are affected or if relatives developed the illness at young ages. These findings reinforce that a thorough family history is a critical indicator of inherited and shared environmental risk factors for common conditions (like cardiovascular disease, diabetes, and many cancers).

References

1. Klemenc-Ketiš Z, Peterlin B (2013). Family history as a predictor for disease risk in healthy individuals: a cross-sectional study in Slovenia — PLOS One 8(11):e80333.
2. Bramhankar M, Pandey M, Tyagi R (2025). The burden of chronic diseases with the status of family medical history among older adults in India — Journal of Prevention 46(1):83–101.

Because family history confers higher risk, medical guidelines often recommend starting screening earlier for at-risk individuals — years before the standard starting age.

Colorectal cancer screening. For colorectal cancer, most people at average risk historically began screening at age 50, but those with a first-degree relative who had colorectal cancer are advised to start at age 40 or 10 years earlier than the relative’s age at diagnosis.³

Following these family-history-based guidelines moves screening earlier. One study of early-onset colorectal cancer found that 98.4% of patients who met family-history-based early-screening criteria could have been recommended to begin screening at an age younger than when their cancer was actually diagnosed.⁴

Benefits of earlier population screening. Even for average-risk populations, lowering the starting age of screening has benefits. The U.S. Preventive Services Task Force now recommends beginning colorectal screening at 45 instead of 50.⁵ Starting 5 years earlier lets clinicians find and remove high-risk growths before they progress to cancer, catching potential cancers at an asymptomatic stage.⁵

Key finding: Family-history-based guidelines move the start of screening earlier — by as much as 5–10 years for people with an affected first-degree relative — so screening can begin before the standard age rather than waiting for symptoms.

References

1. Rex DK, et al.; US Multi-Society Task Force on Colorectal Cancer (2017). Colorectal Cancer Screening: Recommendations for Physicians and Patients — Gastroenterology 153(1):307–323. Advises starting at age 40, or 10 years before a first-degree relative was diagnosed.
2. Gupta S, et al. (2020). Potential impact of family history–based screening guidelines on the detection of early-onset colorectal cancer — Cancer 126(13):3013–3020.
3. US Preventive Services Task Force (2021). Screening for Colorectal Cancer: USPSTF Recommendation Statement — JAMA 325(19):1965–1977.

Genetics do not have to be destiny — research shows that a healthy lifestyle can substantially cut the elevated risk that comes with genetic predisposition.

Heart disease. A landmark study in the New England Journal of Medicine quantified this effect for heart disease: among people with high genetic risk for coronary artery disease, those who consistently practiced a healthy lifestyle (no smoking, regular exercise, healthy diet, and maintaining a healthy weight) had about a 46% lower relative risk of coronary events compared to those with similar genetic risk who had an unhealthy lifestyle.⁶ In other words, favorable lifestyle choices roughly halved the risk in the high-genetic-risk group.

Dementia and Alzheimer’s. Large population studies on dementia have found that a healthy lifestyle is associated with lower risk of cognitive decline even in those genetically predisposed. In a 2019 study of about 196,000 older adults, those at high genetic risk for dementia who followed a favorable lifestyle had roughly a 32% lower risk of dementia than those at high genetic risk with an unfavorable lifestyle (hazard ratio 0.68).⁷

As the CDC’s genomics experts summarized: "while your genome and family history may place you at higher risk for certain diseases, there is evidence that you may be able to lower that risk by living a healthy lifestyle."⁸

Key finding: In people at high genetic risk, a healthy lifestyle has been linked to substantially lower risk — about 46% for coronary disease and roughly a third for dementia — though it lowers risk rather than removing it.

References

1. Khera AV, et al. (2016). Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease — N Engl J Med 375(24):2349–2358.
2. Lourida I, et al. (2019). Association of Lifestyle and Genetic Risk With Incidence of Dementia — JAMA 322(5):430–437.
3. Bowen S, Taylor C, Khoury MJ (2019). Can a Healthy Lifestyle Reduce Your Risk of Dementia Regardless of Your Genes? — CDC Genomics & Precision Health Blog.

Incorporating a complete family history into medical evaluations can meaningfully improve diagnostic accuracy and risk stratification. Numerous studies show that systematically collecting family history information helps identify at-risk patients that might otherwise be missed, leading to more correct or timely diagnoses.

Primary care. A British primary care study developed a brief family history questionnaire for four common diseases (heart disease, diabetes, breast and colon cancer). The tool showed high diagnostic accuracy in flagging people with elevated familial risk — with sensitivity and specificity often in the 80–98% range.¹⁰ Using such a tool, about 32% of adults were found to be at increased risk for at least one common disease, enabling targeted prevention or early monitoring.

Genomics integration. One 2021 study integrated detailed four-generation family histories with DNA sequencing in healthy individuals. Among people with a notable family history of cancer, 1 in 7 were found to carry a clinically actionable genetic variant, compared with about 1 in 47 among those at average family-history cancer risk — roughly a sixfold increase in detecting genetic risk factors when family history was taken into account.¹¹

Health experts emphasize that a complete personal and family history is a cornerstone of clinical risk assessment, helping clinicians identify inherited risks that might otherwise be missed.¹²

Key finding: A thorough family history can significantly boost diagnostic accuracy by alerting providers to inherited risks, prompting earlier screening and additional diagnostic tests.

References

1. Walter FM, et al. (2013). Development and evaluation of a brief self-completed family history screening tool for common chronic disease prevention in primary care — Br J Gen Pract 63(611):e393–e400.
2. Bylstra Y, et al. (2021). Family history assessment significantly enhances delivery of precision medicine in the genomics era — Genome Medicine 13(1):3.
3. Bennett RL (2019). Family Health History: The First Genetic Test in Precision Medicine — Med Clin North Am 103(6):957–966.